Latest Breaking News On - European association for the study of liver - Page 1 : comparemela.com

VCU liver specialist reveals transformative treatment for fatty liver disease

Turbocharging the GLP-1 agonist used to treat diabetes and obesity may transform treatment for patients with fatty liver disease.

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript

Operator: Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.

Global Organ Transplant Market Report 2022: Significant Increase in the Prevalence of Acute Diseases Driving Sector

/PRNewswire/ The "Global Organ Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com s offering. A major element.